Reduktion i varigheden af neutropeni og forekomsten af febril neutropeni hos patienter behandlet med te
Reduction in the duration of neutropenia and the incidence of febrile neutropenia in patients treated with cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and al